Receptos, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
BMYBristol-Myers Squibb Company
JNJJohnson & Johnson
PFEPfizer Inc.
MRKMerck & Co., Inc.
LLYEli Lilly and Company
ABBVAbbVie, Inc.
AZNAstraZeneca PLC Sponsored ADR
NVSNovartis AG Sponsored ADR
GSKGlaxoSmithKline plc Sponsored ADR
NVONovo Nordisk A/S Sponsored ADR Class B
SNYSanofi Sponsored ADR
LCILannett Company, Inc.
AKTXAkari Therapeutics Plc Sponsored ADR

Company Profile

Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in Delaware.